1,1'-[Propane-1,3-diylbis(piperidine-4,1-diyl)]bis(ethanone), 250mg

6-Hydroxy-2-oxo-1,2,3,4-tetrahydroquinoline, 97.0%, 100g

TERT-BUTYL OXIRANE-2-CARBOXYLATE, 95.0%, 1g

Imidazole [for Buffer]>99.0%(GC)(T)25g

4-Pyrrolidin-1-yl-benzoic acid, 95.0%, 5g

N-DBCO-N-bis(PEG2-C2-NHS ester), 25mg

4-Bromo-4'-(4-bromophenyl)-3',5',6'-triphenyl-1,1':2',1''-terphenyl, 98%, 5g

Methyl 2,3,6-Tri-O-benzoyl-alpha-D-galactopyranoside>98.0%(HPLC)25g

Asa de inoculación estéril, 1 μl, 0,9 mm, suelta 250 uds.

[S(R)]-N-[(R)-[6-(Diphenylphosphino)benzo[d][1,3]dioxol-5-yl]-1-naphthalenylmethyl]-2-methyl-2-propanesulfinamide, 95%, 25mg

(R)-2-((1-Phenylethyl)amino)acetic acid, 98.0%, 10g

BENZYL 4-OXO-3,4-DIHYDROPYRIDINE-1(2H)-CARBOXYLATE, 95.0%, 50g

3-Bromo-6-(tert-butyl)pyridazine, 96%, 1g